Monday, July 11, 2022 1:51:41 PM
BY Benzinga
— 1:29 PM ET 07/11/2022
$HTGM HTG Molecular Diagnostics will be granted US patent number 11,384,399 tomorrow titled "METHODS FOR SUBTYPING DIFFUSE LARGE B-CELL LYMPHOMA (AND USING THE RESULTS FOR DIAGNOSIS, PROGNOSIS, AND THERAPY SELECTION)". pic.twitter.com/SWg0maPEZi
— PatentGrants (@PatentGrants) July 11, 2022
Janey says: have you seen my wig around? I feel naked without it.
Recent HTGMQ News
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 07/10/2023 10:06:57 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM